Targeting obesity-related dysfunction in hormonally driven cancers.
Ontology highlight
ABSTRACT: Obesity is a risk factor for at least 13 different types of cancer, many of which are hormonally driven, and is associated with increased cancer incidence and morbidity. Adult obesity rates are steadily increasing and a subsequent increase in cancer burden is anticipated. Obesity-related dysfunction can contribute to cancer pathogenesis and treatment resistance through various mechanisms, including those mediated by insulin, leptin, adipokine, and aromatase signalling pathways, particularly in women. Furthermore, adiposity-related changes can influence tumour vascularity and inflammation in the tumour microenvironment, which can support tumour development and growth. Trials investigating non-pharmacological approaches to target the mechanisms driving obesity-mediated cancer pathogenesis ar
SUBMITTER: Rubinstein MM
PROVIDER: S-EPMC8368182 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA